Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios

Objectives Treatment for advanced renal cell carcinoma (RCC) has become increasingly more complex over the last several years. Objective 1 is to which treatment option is immunotherapy, targeted therapy, or the combination of immunotherapy with targeted therapy the best for patients? Objective 2 is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International urology and nephrology Jg. 51; H. 12; S. 2107 - 2117
Hauptverfasser:	Cetin, Bulent, Kosar, Alim
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Dordrecht Springer Netherlands 01.12.2019 Springer Nature B.V
Schlagworte:	Aged Carcinoma, Renal Cell - therapy Clear cell-type renal cell carcinoma Clinical trials Clinical Trials as Topic Decision making Drug development Female Humans Immune checkpoint inhibitors Immunotherapy Kidney cancer Kidney Neoplasms - therapy Male Medicine Medicine & Public Health Metastases Metastasis Middle Aged Molecular Targeted Therapy Monoclonal antibodies Nephrology Patients Risk groups Targeted cancer therapy Tyrosine Urology Urology - Review Vascular endothelial growth factor Metastatic renal cell carcinoma Immunotherapy Tyrosine kinase inhibitors
ISSN:	0301-1623, 1573-2584, 1573-2584
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!